Immunogenic peptides and their use in immune disorders

Details for Australian Patent Application No. 2007283731 (hide)

Owner Life Sciences Research Partners vzw

Inventors Saint-Remy, Jean-Marie

Agent Spruson & Ferguson

Pub. Number AU-A-2007283731

PCT Pub. Number WO2008/017517

Priority 0710081.1 25.05.07 GB; 0615966.9 11.08.06 GB; 0711403.6 13.06.07 GB

Filing date 13 August 2007

Wipo publication date 14 February 2008

International Classifications

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/017517 Priority application(s): WO2008/017517

29 March 2012 Assignment before Grant

  Life Sciences Research Partners vzw The application has been assigned to Life Sciences Research Partners vzw; Katholieke Universiteit Leuven, K.U.Leuven R&D

26 April 2012 Corrigenda

  Assignments Before Grant, Section 113 - 2007 Under the name Katholieke Universiteit Leuven, K.U. Leuven R&D, Application No. 2007283731 Under INID (71), correct the applicant name to Katholieke Universiteit Leuven

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007283732-Genetically modified plants which synthesize a starch having increased swelling power

2007283729-Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy